Myopathy in Anti-IgLON5 Disease, An ALS Mimic

The provided research investigates how anti-IgLON5 disease, a neurological disorder, frequently manifests through neuromuscular symptoms such as proximal limb weakness, muscle wasting, and fasciculations. By examining a cohort of Dutch patients, researchers discovered that over half exhibited signs of myopathy, a clinical feature previously underreported or misunderstood in this condition. Analysis of muscle biopsies revealed consistent abnormalities and a notable increase in IgLON5 protein expression, suggesting the molecule is vital for healthy muscle fiber repair. The study proposes that patient antibodies likely disrupt the regeneration of muscle tissue, leading to the observed physical decline. These findings significantly expand the known clinical phenotype of the disease, providing doctors with crucial diagnostic clues to identify the condition earlier. Ultimately, recognizing these muscular signs can facilitate the prompt initiation of immunotherapy, which may improve long-term patient outcomes.